3.0.0 3520 2022-11-01T13:50:52Z 2022-11-01T13:50:52Z House HR 2019-06-26 116 [Congressional Record Volume 165, Number 108 (Wednesday, June 26, 2019)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. SMITH of New Jersey:H.R. 3520.Congress has the power to enact this legislation pursuantto the following:The constitutional authority on which this bill is based isin Congress's power under the Spending Clause in Article I,Section 8 of the Constitution.[Page H5202]]]> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2019-06-27T19:27:39Z Referred to 2019-06-26T14:05:45Z TRANSPLANT Act of 2020 116 4764 HR 2020-12-14 Message on Senate action sent to the House. Related bill CRS TRANSPLANT Act of 2020 116 4672 S 2020-09-23 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5835) Related bill CRS 2019-06-27 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2019-06-26 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2019-06-26 Introduced in House IntroReferral Intro-H 9 Library of Congress 2019-06-26 Introduced in House IntroReferral 1000 9 Library of Congress S000522 Rep. Smith, Christopher H. [R-NJ-4] CHRISTOPHER SMITH R NJ H. 4 N B001257 Rep. Bilirakis, Gus M. [R-FL-12] Gus Bilirakis R FL M. 12 2019-06-26 True A000378 Rep. Axne, Cynthia [D-IA-3] Cynthia Axne D IA 3 2019-08-02 False L000569 Rep. Luetkemeyer, Blaine [R-MO-3] Blaine Luetkemeyer R MO 3 2019-09-17 False Health Advisory bodies Blood and blood diseases Cell biology and embryology Health programs administration and funding Medical research Organ and tissue donation and transplantation Research administration and funding Health 00 2019-06-26 Introduced in House 2020-12-15T16:44:31Z Stem Cell Therapeutic and Research Reauthorization Act of 2019

This bill modifies and reauthorizes through FY2024 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also reauthorizes through FY2024 the Stem Cell Therapeutic and Research Act of 2005, which provides for the collection and maintenance of new units of high-quality cord blood.

The bill requires the Advisory Council on Blood Stem Cell Transplantation to convene at least twice per calendar year.

]]> Stem Cell Therapeutic and Research Reauthorization Act of 2019 Display Title Stem Cell Therapeutic and Research Reauthorization Act of 2019 Official Title as Introduced To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. Introduced in House IH Short Title(s) as Introduced Stem Cell Therapeutic and Research Reauthorization Act of 2019 Introduced in House IH Introduced in House 2019-06-26T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116hr3520ih/xml/BILLS-116hr3520ih.xml 2019-06-27 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.